Does SIPULEUCEL-T Cause Hormone-refractory prostate cancer? 10 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hormone-refractory prostate cancer have been filed in association with SIPULEUCEL-T (PROVENGE). This represents 0.2% of all adverse event reports for SIPULEUCEL-T.
10
Reports of Hormone-refractory prostate cancer with SIPULEUCEL-T
0.2%
of all SIPULEUCEL-T reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hormone-refractory prostate cancer From SIPULEUCEL-T?
Of the 10 reports.
Is Hormone-refractory prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPULEUCEL-T. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does SIPULEUCEL-T Cause?
Chills (447)
Infusion related reaction (414)
Pyrexia (255)
Fatigue (249)
Malaise (233)
Nausea (205)
Disease progression (185)
Ill-defined disorder (185)
Culture positive (174)
Asthenia (164)
What Other Drugs Cause Hormone-refractory prostate cancer?
RADIUM RA-223 DICHLORIDE (441)
LEUPROLIDE (180)
DOCETAXEL (123)
ENZALUTAMIDE (120)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (110)
DAROLUTAMIDE (104)
ABIRATERONE (83)
PREDNISONE (58)
CABAZITAXEL (57)
BICALUTAMIDE (50)
Which SIPULEUCEL-T Alternatives Have Lower Hormone-refractory prostate cancer Risk?
SIPULEUCEL-T vs SIROLIMUS
SIPULEUCEL-T vs SIRUKUMAB
SIPULEUCEL-T vs SITAGLIPTIN
SIPULEUCEL-T vs SOAP
SIPULEUCEL-T vs SODIUM